Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemodynamic and metabolic alterations during experimental sepsis in young and adult rats.

Surgery, gynecology & obstetrics·1989
Same author

Intranasal LH-RH treatment of cryptorchidism. A clinical trial and 5 years follow-up.

European journal of pediatrics·1987
Same author

[Status after 5-year hormonal treatment (LH-RH) for non-descended testis].

Ugeskrift for laeger·1986
Same author

Late return of function after intrathoracic torsion of the spleen in congenital diaphragmatic hernia.

Journal of pediatric surgery·1986
Same author

Benign ureteral polyp as a cause of intermittent hydronephrosis in a child.

The Journal of urology·1981
Same author

[Intranasal administration of the gonadotropin-releasing hormone (LH-RH) in the treatment of undescended testis].

Ugeskrift for laeger·1981

Related Experiment Video

Updated: Jul 12, 2026

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

Novel approach to bioavailability testing: statistical method for comparing drug input calculated by a least-squares

P V Pedersen

    Journal of Pharmaceutical Sciences
    |March 1, 1980
    PubMed
    Summary

    A new model-independent bioavailability testing method is introduced. This approach enhances drug input comparison without pharmacokinetic assumptions, offering a more detailed bioavailability analysis.

    More Related Videos

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
    08:59

    An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

    Published on: December 3, 2020

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
    12:17

    An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

    Published on: May 8, 2017

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
    08:59

    An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

    Published on: December 3, 2020

    Area of Science:

    • Pharmacokinetics
    • Drug bioavailability
    • Biopharmaceutics

    Background:

    • Traditional bioavailability testing often relies on specific pharmacokinetic models.
    • These models require assumptions about absorption, distribution, and elimination rates.
    • A need exists for a more flexible and intrinsic method for bioavailability evaluation.

    Purpose of the Study:

    • To introduce a novel, model-independent approach for bioavailability testing.
    • To enable a more detailed and intrinsic comparison of drug input characteristics.
    • To provide a method that does not rely on pharmacokinetic rate constants or volume terms.

    Main Methods:

    • The proposed method requires intravenous drug administration.
    • It evaluates drug input based on assumptions similar to those for area under the curve calculations.
    • No extrapolation beyond the last data point is necessary.

    Main Results:

    • Two key statistics are derived for comparing the rate and cumulative amount of drug input over time.
    • A differential confidence profile is calculated for enhanced bioavailability comparison.
    • The method demonstrated satisfactory performance on simulated data with random noise.

    Conclusions:

    • The novel model-independent approach offers a robust alternative for bioavailability testing.
    • It provides a more intrinsic comparison of drug input characteristics than traditional methods.
    • This method simplifies bioavailability assessment by avoiding complex pharmacokinetic modeling.